Hyperfine
HYPR
42 hedge funds and large institutions have $40.9M invested in Hyperfine in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 4 closing their positions.
1,725% more call options, than puts
Call options by funds: $73K | Put options by funds: $4K
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
17% more funds holding
Funds holding: 36 → 42 (+6)
0.13% more ownership
Funds ownership: 32.02% → 32.15% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
36% less capital invested
Capital invested by funds: $63.6M → $40.9M (-$22.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$2.94M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$1.56M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$442K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$431K |
| 5 |
Jane Street
New York
|
+$213K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.24M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$1.1M |
| 3 |
PA
Perceptive Advisors
New York
|
-$1.08M |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$270K |
| 5 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
-$174K |
HYPR Hedge Fund Activity: Q2 2022 in Review
42 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Hyperfine (HYPR) for Q2 2022, worth a combined $40.9M — down 36% from $63.6M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HYPR positions and 4 closed out — a net gain of 6 holders — while 9 added to existing stakes and 9 trimmed.
The largest buyer was HealthCor Management, adding an estimated $2.94M. The largest seller was Vanguard Group, cutting an estimated $3.24M.
- 42 institutional investors held Hyperfine (HYPR) as of Q2 2022, up from 36 in Q1 2022.
- Funds reported $40.9M of Hyperfine stock for Q2 2022, down 36% quarter-over-quarter.
- 10 funds opened new Hyperfine positions in Q2 2022 and 4 closed out, a net change of +6 holders.
- The largest Hyperfine buyer in Q2 2022 was HealthCor Management, an estimated $2.94M added.
- The largest Hyperfine seller in Q2 2022 was Vanguard Group, an estimated $3.24M sold.
Based on aggregated 13F filings for Q2 2022.